Ranbaxy Laboratories has posted a 89.91 per cent decline in its consolidated net profit at Rs 125.75 crore for the first quarter ended March 31, 2013.
The company had posted a net profit of Rs 1,246.76 crore in the same period of previous year.
In a filing to the Bombay Stock Exchange,
Ranbaxy Laboratories said net sales of the company declined to Rs 2,439.82 crore for the January-March quarter, compared to Rs 3,708.97 crore in the same period of 2012.
Ranbaxy shares closed 2.78 per cent down at Rs 443.80 on BSE.
Special 
